Effects of ultrasound pregnancy dating on neonatal morbidity in late preterm and early term male infants: a register-based cohort study by unknown
RESEARCH ARTICLE Open Access
Effects of ultrasound pregnancy dating on
neonatal morbidity in late preterm and
early term male infants: a register-based
cohort study
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Abstract
Background: Assessing gestational age by ultrasound can introduce a systematic bias due to sex differences in
early growth.
Methods: This cohort study included data on 1,314,602 births recorded in the Swedish Medical Birth Register. We
compared rates of prematurity-related adverse outcomes in male infants born early term (gestational week 37–38)
or late preterm (gestational week 35–36), in relation to female infants, between a time period when pregnancy
dating was based on the last menstrual period (1973–1978), and a time period when ultrasound was used for
pregnancy dating (1995–2010), in order to assess the method’s influence on outcome by fetal sex.
Results: As expected, adverse outcomes were lower in the later time period, but the reduction in prematurity-
related morbidity was less marked for male than for female infants. After changing the pregnancy dating method,
male infants born early term had, in relation to female infants, higher odds for pneumothorax (Cohort ratio [CR] 2.
05; 95 % confidence interval [CI] 1.33–3.16), respiratory distress syndrome of the newborn (CR 1.99; 95 % CI 1.33–2.
98), low Apgar score (CR 1.26; 5 % CI 1.08–1.47), and hyperbilirubinemia (CR 1.12; 95 % CI 1.06–1.19), when outcome
was compared between the two time periods. A similar trend was seen for late preterm male infants.
Conclusion: Misclassification of gestational age by ultrasound, due to size differences, can partially explain currently
reported sex differences in early term and late preterm infants’ adverse neonatal outcomes, and should be taken
into account in clinical decisions and when interpreting study results related to fetal sex.
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Background
The use of ultrasound (US) has an unquestionable role in
modern obstetrical practice. In many countries, as in
Sweden, fetal biometry is the recommended single method
for estimation of gestational age (GA) and estimated deliv-
ery date (EDD), and the date of the last menstrual period
(LMP) is only used when no US estimate is available [1].
In other countries, the estimation is based on the date of
the LMP or a combination of both methods.
Biometry using US in the first or second trimester is
generally a more precise method for assessing GA and
pregnancy dating, than estimates based on the date of
the LMP [2]. Estimates are more precise when they are
based on first-trimester rather than second-trimester bi-
ometry [3, 4]. Early differences in fetal growth do exist
[5–7], but it has been assumed that individual variation
is too small to have any clinical significance [8]. Recent
studies challenge this assumption [9–12]. For example,
second-trimester US dating underestimates GA and
overestimates preterm delivery rates in infants born
small for gestational age (SGA) [12]. Furthermore, post-
poning the date of estimated delivery by 7 days by US is
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associated with birth of SGA infants [11], increased risk
of stillbirth, low Apgar score, and neonatal death [10].
The reported sex differences in early fetal growth [7, 8]
can be used as one example among many other variables
possibly affecting the accuracy of US-based estimation of
GA. In a study by Skalkidou et al., increased mortality and
morbidity in post-term female infants in relation to male
infants was seen after US was introduced in Sweden as the
method for assessing GA [9]. This increase in mortality and
morbidity can reflect the fact that girls born post-term may
be more mature than their US-based GA indicates, as their
EDD was moved forward in time because of their smaller
size at the time of ultrasound pregnancy dating.
According to this hypothesis, male fetuses could be less
mature than the US-based GA estimate, since the ap-
proximation of GA from fetal size used during ultrasound
dating would not consider size differences. In Sweden, a
second trimester scan, using the biparietal diameter
(BPD)-measurement for pregnancy dating, is typically per-
formed around gestational week 18 at what time the mean
difference (male vs. female) in BPD is considered to be
1 mm [5]. An introduced bias in the GA estimate, due to
size difference by fetal sex at the time of pregnancy dating,
would be hypothesized to affect clinical management and
neonatal outcomes in the late preterm and early term
period. Although often treated as term, late preterm in-
fants more commonly present with prematurity-related
morbidity such as hyperbilirubinemia, respiratory distress
syndrome (RDS) of the newborn, transient tachypnea of
the newborn, interventions to support breathing, and
readmissions for hospital care [13].
Our hypothesis was that a change in the method of
dating pregnancy might have led to an increased risk for
prematurity-related adverse outcomes among male in-
fants in relation to female infants by introducing a mis-
classification bias due to sex differences in early growth.
The aim of this study was to compare rates of adverse
prematurity-related outcomes in early term and late pre-
term male infants in relation to their female counter-
parts, between a time period, when pregnancy dating
was based on the LMP, and a time period when ultra-
sound was used for pregnancy dating, in order to assess
the dating method’s influence on prematurity-related ad-
verse outcomes by fetal sex.
Methods
In this study, we used data on 1,314,602 births in Sweden
to compare adverse outcomes related to prematurity be-
tween male and female infants by method of pregnancy
dating (US or from LMP). We compared prevalence of
outcomes between sexes in a time period when LMP was
used as the only method for dating pregnancies (1973–
1978) and similarly the prevalence of outcomes were com-
pared between sexes after US was introduced as the
method for dating pregnancies (1995–2010). The risk esti-
mates, by fetal sex, that were generated for each of the
two time periods were then compared.
Information was collected from the Swedish Medical
Birth Register (MBR), which contains information on
more than 99 % of all births in Sweden since 1973. For
the purposes of the current study, the period between
1978 and 1995 was not included since policies on the
method for pregnancy dating and registration of the US-
based EDD were not uniform throughout the country.
The register includes data about maternal socio-
demographic characteristics and prospectively collected
information during pregnancy, delivery, and the neonatal
period (first 28 days) [14]. The register has been evalu-
ated as reliable for research purposes, with good internal
validity [15]. Diagnoses are classified and recorded by
the treating physician or midwife according to the Inter-
national Classification of Diseases (ICD). The version
used during 1973–1978 was ICD-8, while during 1995–
2010 the versions were ICD-9 and ICD-10.
Up to 1978, practically all clinics were using the LMP
date in order to calculate the EDD. With the introduction
of US in Sweden, the practice was changed to estimate the
EDD from second-trimester US biometry irrespective of
the LMP date [1]. Before 1980, fewer than 5 % of hospitals
practiced US scanning. By contrast, from 1995 on, nearly
all clinics based EDD assessment on US biometry and
documented the EDD-US in the MBR. Routine US scan-
ning has been offered to all pregnant women since 1990,
and more than 95 % of the women accept this offer [14].
Such routine scanning is typically performed early in the
second trimester (gestational weeks 17–19) for assessing
GA, detection of multiple births, placental location, and
congenital anomalies [1]. According to a 1996 study, when
59 clinics in Sweden provided obstetric and antenatal care,
US scanning was performed at gestational weeks 16–20 in
52 clinics and at 10–15 weeks in three clinics [1]. Since
then, the use of first-trimester US has increased gradually.
Our study population consisted of two cohorts includ-
ing all singleton births in Sweden, with valid birth dates
for both mother and infant, from 1973 to 1978 (GA as-
sessment based on the LMP date) and from 1995 to
2010 (GA assessment by US).
Information was retrieved on GA at delivery (based on
LMP date and US assessment, respectively), the level of
the hospital, maternal age, parity, infant sex, Apgar score
[16], any neonatal deaths, and diagnoses of adverse out-
comes related to late prematurity. Diagnoses that
allowed comparison between the ICD versions and with
higher incidence among premature infants were chosen.
These were: pneumothorax P25 (ICD-10), 7702 (ICD-9),
77620, and 77625 (ICD-8); RDS P22.0 (ICD-10), 769
(ICD-9), and 7761 (ICD-8); other respiratory conditions
such as P22.1, P22.8, P22.9, P28.3, P28.4 (ICD-10), 7706,
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7708 (ICD-9), 77629, 77699, and 77680 (ICD-8); hyper-
bilirubinemia P55, P57, P58, P59 (ICD-10), 7730, 7731,
7732, 7734, 7735, 774 (ICD-9), 774, 775, and 77893
(ICD-8) [17–21].
For the purposes of this study, infants were classified into
three groups: those born from 39 weeks + 0 days to
40 weeks + 6 days (273–286 days, designated midterm);
from 37 weeks + 0 days to 38 weeks + 6 days (259–272
days, designated early term); and from 35 weeks + 0 days to
36 weeks + 6 days (245–258 days, hereby referred to as late
preterm). We chose to use 2-week intervals to create
groups of equal length for comparison. The common defin-
ition of late preterm infants also includes infants born from
34 weeks + 0 days to 34 weeks + 6 days (238–244 days), but
these infants were not included in the current study in
order to reduce possible misclassification by the inclusion
of moderately preterm infants.
Data on the study population were cross-tabulated by
infant sex, GA, and the two time periods (1973–1978 and
1995–2010). As a first step, rates of adverse outcomes per
1000 live births were calculated according to infant sex,
GA, and the studied period. Thereafter, for each time
period, using the gestational age categories as the expos-
ure variable (early term and late preterm infants, respect-
ively, with midterm infants as the reference category), we
used logistic regression to estimate odds for prematurity-
related adverse outcomes such as neonatal death, low
Apgar score (<7 at 5 min), pneumothorax, RDS, other re-
spiratory conditions, and hyperbilirubinemia. Then, for
each time period, odds ratios (ORs) with 95 % confidence
intervals (CIs) for adverse prematurity-related outcomes
among male infants, always in relation to their female
counterparts, were calculated with logistic regression, sep-
arately for early term and for late preterm infants. Finally,
to estimate the change in male risk before and after the
introduction of ultrasound pregnancy dating, the relative
change in odds for adverse prematurity-related outcomes
between the two periods, among male infants in the early
term and late preterm groups in relation to their female
counterparts, was calculated as the ratio between the ORs
for each period (Cohort Ratio, CR). The multivariate ana-
lyses were adjusted for maternal age, parity, and level of
hospital care.
The statistical analyses were conducted using the SAS
9.3 software package (SAS Institute, Cary, NC, USA).
The ORs and CRs with their 95 % confidence intervals
were estimated with the GENMOD procedure.
Results
The characteristics of the study cohorts are presented in
Table 1, with the number of male and female infants
born in each GA group during 1973–1978 and 1995–
2010. The proportion of midterm births (74.6 % in the
early vs. 70.5 % in the late period) was higher in the early
cohort, and the proportion of early term births (21.0 %
in the early vs. 25.5 % in the late period) was lower in
the early cohort. The proportion of late preterm births
was similar in the two cohorts (4.3 % in the early vs.
4.0 % in the late period). Mean maternal age for the first
time period (1973–1978) was 27 years (SD = 5), and
mean maternal age in the later time period (1995–2010)
was 30 (SD = 5).
Table 2 demonstrates rates of prematurity-related ad-
verse outcomes by sex and gestational age in the two
time periods. The ORs for adverse outcomes are pre-
sented with midterm infants of the same sex as the ref-
erence category. Rates of adverse neonatal outcomes
were generally lower for both male and female infants in
the later period. Rates of adverse outcomes were lower
for female infants than for male infants, in both time pe-
riods, with the exception of neonatal death among late
preterm infants in the later period. ORs for prematurity-
related outcomes were lower for early term infants, than
for late preterm infants, as expected.
Table 3 includes the ORs for prematurity-related ad-
verse outcomes among early term male infants, with fe-
male infants as reference category, in the two time
periods. ORs for adverse outcomes were higher for all
comparisons in relation to female infants. Comparing the
two time periods, ORs for male infants were increased in
the second study period, as reflected by the statistically
significant cohort ratios (CR). Between the two time pe-
riods, there was an increase in odds for early term male
infants, in relation to females, for pneumothorax (CR
2.05, CI 1.33–3.16), RDS (CR 1.99, CI 1.33–2.98), a low
Apgar score (CR 1.26, CI 1.08–1.47), other respiratory
conditions (CR 1.14, CI 1.00–1.30), and hyperbilirubine-
mia (CR 1.12, CI 1.06–1.19) in the later time period. There
was no significant change in cohort ratios for perinatal
mortality (Table 3).
In Table 4, the corresponding ORs, but instead in late
preterm male infants, are presented. The ORs for adverse
outcomes for male late preterm infants in relation to fe-
males were significantly higher for all outcomes in both
time periods, except for neonatal mortality. Late preterm
male infants in comparison to females had increased risks
for other respiratory conditions in the latter time period
(CR 1.22, CI 1.02–1.45). Despite not reaching statistical
significance, all other CRs for neonatal morbidity were
positive for late preterm infants, following the same trend
as in early term infants.
There were practically no differences in the results
when births by cesarean section delivery were excluded
(Additional file 1).
Discussion
After the introduction of US for pregnancy dating in
Sweden, the risk of prematurity-related adverse outcomes
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was increased among male infants born at early term rela-
tive to that of female infants. A similar trend was observed
for late preterm male infants. The relative increase in male
risks was in line with a less marked reduction of
prematurity-related morbidity among male than among
female infants in the later time period. This was also con-
sistent with the hypothesized introduction of a misclassifi-
cation bias after the introduction of US-biometry as the
method of assessing GA. As male fetuses are usually larger
than their female counterparts, they may be considered
older at the time of US dating and their EDD will be
moved backward in time. Thus, at birth, male infants
would be less mature and at greater risk for prematurity-
related adverse outcomes.
The assessment of GA by US has had beneficial ef-
fects, such as a reduction in the need for the induction
of labor for prolonged pregnancy [22] and improved
pregnancy outcomes [23]. However, the adverse effects
of US pregnancy dating also need to be considered. Vari-
ations in early growth related to fetal or maternal factors
leading to misclassification of GA can affect morbidity
and mortality in selected groups, such as post-term fe-
male infants [9]. In a large study comparing the GA
based on second-trimester US biometry with the GA
based on the date of embryo transfer after in vitro
fertilization (IVF), an underestimation of GA with US bi-
ometry was observed among infants later diagnosed as
SGA [6]. These results were replicated in the Extremely
Preterm Infants in Sweden Study, in which a discrepancy
of seven days or more between US-based and LMP-
based estimation of GA was associated with an increased
risk of being born SGA [24]. Similarly, fetal sex, which
affects the assessment of GA by US [5, 12], could also
affect perinatal outcomes, consistent with the results of
this study.
We found that there were more significant increases
in odds for adverse outcomes among early term male in-
fants than among late preterm ones. An explanation for
this finding could be that routines for neonatal care de-
pend on the assessed GA. Concerns have been expressed
regarding the lack of awareness of the special needs for
care of late preterm infants compared with the intense
management efforts for more preterm ones [13]. This
reasoning could also be applied when comparing early
term and late preterm infants. Early term infants, that
were actually late preterm, would be expected to cope
well and would receive less attention than needed,
whereas late preterm infants, that were actually more
preterm, would anyway receive active care from birth.
There were more children born early term than late pre-
term, which reduced to some extent the power for ana-
lyses of outcome in the late preterm group.
By focusing on comparisons of male relative to female
risks in both study periods, we tried to minimize the risk
of bias. With this design, a possible bias would have had
to selectively affect the outcomes for either male or fe-
male infants, and be more prevalent in only one of the
study periods, to affect the outcome of the final analyses.
The improvements in neonatal medicine during the end
of the last century have actually favored boys to a higher
Table 1 Number and distribution of two cohorts of singleton births in Sweden, with mean and standard deviation (SD) of
birthweight, birth length, and Apgar score by infant sex and gestational age, before and after the implementation of ultrasound for
pregnancy dating
1973–1978 1995–2010
Male Female Male Female
Gestational age N % N % N % N %
35–40 weeks 187,163 100.0 170,375 100.0 479,118 100.0 477,946 100.0
35–36 weeks 8,737 4.7 6,733 4.0 20,527 4.3 18,095 3.8
37–38 weeks 41,434 22.1 33,746 19.8 122,074 25.5 121,500 25.4
39–40 weeks 136,992 73.2 129,896 76.2 336,517 70.2 338,351 70.8
Gestational age Infant characteristics Mean SD Mean SD Mean SD Mean SD
35–36 weeks Birthweight (g) 2,850 499 2,749 503 2,846 452 2,778 461
Birth length (cm) 47.9 2.5 47.3 2.4 47.6 2.2 47.0 2.2
Apgar score 9.2 1.3 9.2 1.3 9.5 1.0 9.6 1.0
37–38 weeks Birthweight (g) 3,284 472 3,159 465 3,349 460 3,254 450
Birth length (cm) 49.7 2.1 48.9 2.1 49.6 2.0 48.9 2.0
Apgar score 9.5 0.9 9.5 0.9 9.8 0.7 9.8 0.6
39–40 weeks Birthweight (g) 3,591 463 3,451 446 3,665 451 3,544 437
Birth length (cm) 51.0 2.0 50.1 2.0 51.0 1.9 50.2 1.8
Apgar score 9.6 0.8 9.6 0.7 9.8 0.7 9.8 0.6
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degree than girls, possibly because of their excess inher-
ent vulnerability and higher risk for prematurity [25].
During the two time periods in this study, maternal age
at childbirth increased, which should not have affected
the outcome variables in a sex-specific way. Further, ma-
ternal obesity rates increased in the general population
during the study period, but there is no known associ-
ation of obesity with infant sex. The Swedish MBR did
not include the variable ‘weight at first antenatal visit’
until 1992, and therefore information on weight or body
mass index could not be adjusted for in the analyses, nor
was information on smoking available for comparison.
Smoking decreased during the study periods, but it is
not thought to affect prematurity-related outcomes in a
sex-specific way. An increasing proportion of cesarean
deliveries is affecting male infants to a higher degree in
some studies [26, 27]. Cesarean section could not act as
a true confounder, as is does not affect infant sex (ex-
posure) but only the outcome. When cesarean deliveries
were excluded from analyses, there were only minimal
differences in the results. The lower neonatal mortality
in the more recent cohort, as well as the narrowing of
the mortality gap between male and female infants, are
consistent with other reports [28, 29].
Changes in the classification of diagnoses in the
three different versions of the ICD system limited the
numbers of diagnoses that could be included in the
analyses. Other possible limitations to the study were
changes in diagnosis registration and clinical manage-
ment guidelines between the two periods, which could
apply to pneumothorax, hyperbilirubinemia, and re-
spiratory conditions. Such changes could have affected
male and female infants differently, although medical
advances would more likely have favored male infants,
Table 2 Rates and adjusteda odds ratios (OR) with 95 % confidence intervals (95 % CI) for prematurity-related adverse outcomes by
gestational age (GA) at birth among infants born at 35–36 weeks or 37–38 weeks, compared with 39–40 weeks, before and after the






Male infants Female infants Male infants Female infants
Rate/1000 OR (95 % CI) Rate/1000 OR (95 % CI) Rate/1000 OR (95 % CI) Rate/1000 OR (95 % CI)
Neonatal death
35–36 20.7 10.9 (8.97–13.1) 18.1 11.0 (8.81–13.8) 4.9 9.45 (7.39–12.1) 5.2 11.0 (8.48–14.2)
37–38 5.6 2.88 (2.42–3.44) 4.4 2.62 (2.13–3.24) 1.3 2.49 (2.01–3.09) 1.0 2.01 (1.58–2.55)
39–40 1.9 1.00 (ref) 1.7 1.00 (ref) 0.5 1.00 (ref) 0.5 1.00 (ref)
Apgar score <7 at 5 min
35–36 40.7 4.61 (4.08–5.21) 37.9 5.25 (4.55–6.06) 24.8 2.99 (2.71–3.29) 19.8 3.02 (2.69–3.38)
37–38 14.4 1.63 (1.48–1.80) 13.5 1.88 (1.68–2.11) 9.0 1.13 (1.06–1.22) 6.7 1.08 (0.99–1.17)
39–40 8.8 1.00 (ref) 7.2 1.00 (ref) 7.9 1.00 (ref) 6.2 1.00 (ref)
Pneumothorax
35–36 7.6 8.87 (6.53–12.0) 4.5 7.82 (5.10–12.0) 6.7 3.92 (3.25–4.73) 3.0 2.99 (2.24–3.99)
37–38 2.0 2.32 (1.74–3.08) 1.4 2.41 (1.66–3.50) 2.3 1.41 (1.22–1.63) 0.8 0.83 (0.66–1.04)
39–40 0.8 1.00 (ref) 0.5 1.00 (ref) 1.6 1.00 (ref) 0.9 1.00 (ref)
RDSb
35–36 30.6 33.1 (26.8–41.0) 17.8 35.6 (26.3–48.2) 16.2 82.6 (63.6–107) 8.6 63.6 (45.9–88.3)
37–38 3.7 3.91 (3.09–4.95) 2.6 5.09 (3.69–7.01) 1.3 6.33 (4.76–8.42) 0.5 3.22 (2.18–4.75)
39–40 0.9 1.00 (ref) 0.5 1.00 (ref) 0.2 1.00 (ref) 0.1 1.00 (ref)
Other respiratory conditions
35–36 49.2 6.44 (5.74–7.22) 38.0 7.18 (6.20–8.31) 100.0 7.07 (6.70–7.46) 65.3 6.50 (6.08–6.96)
37–38 18.9 2.42 (2.21–2.66) 12.0 2.22 (1.96–2.51) 27.6 1.87 (1.79–1.95) 15.4 1.51 (1.43–1.60)
39–40 7.8 1.00 (ref) 5.4 1.00 (ref) 14.9 1.00 (ref) 10.2 1.00 (ref)
Hyperbilirubinemia
35–36 238.5 5.88 (5.56–6.21) 219.5 7.62 (7.14–8.13) 292.7 16.5 (15.9–17.1) 261.2 18.8 (18.0–19.6)
37–38 113.4 2.41 (2.32–2.51) 98.5 2.97 (2.84–3.11) 53.0 2.33 (2.25–2.41) 40.9 2.39 (2.30–2.48)
39–40 50.0 1.00 (ref) 35.2 1.00 (ref) 23.5 1.00 (ref) 17.6 1.00 (ref)
a Adjusted for maternal age, parity, and level of hospital care
b Respiratory distress syndrome of the newborn
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and would have only attenuated the associations found
in this study. It is unlikely that diagnoses were re-
corded differently by sex of the infant, and, moreover,
it could only have introduced a bias in the registered
outcomes if this occurred in one, and not the other, of
the studied time periods. One of the major strengths
of this work was that the current study’s results are in
line with our and others previous studies’ hypothesis
on possible misclassification by fetal sex, as increased
odds for prematurity-related outcomes among late
preterm and early term male infants is consistent with
increased risks for postmaturity-related adverse out-
come in post-term female infants [7, 9]. Another
major strength of this register-based study was the
large study population, with adequate power for the
statistical analyses. The MBR includes practically all
births in Sweden since 1973, which accounts for high
external validity. However, only singleton pregnancies
are included in this study. When considering wider ex-
ternal validity, it can be argued that population-based
differences in fetal growth exist, which can be attrib-
uted both to genetic, medical, and social factors.
However, in the Intergrowth-project, the fetal skeletal
measurements were similar among the included
healthy and well-nourished women from eight geo-
graphically diverse populations [30]. During the later
period, US dating in the first trimester instead of the
second trimester increased in Sweden. Nevertheless,
this could only have led to an attenuation of the ob-
served associations, as measurements in earlier gesta-
tion have less variance and would have reduced the
degree of misclassification of GA [3, 4].
Gestational length at delivery strongly correlates with
neonatal outcome, and the estimated gestational length
is important for clinical decision-making. Therefore, it is
important to evaluate the methods for assessing GA crit-
ically, and to identify fetuses that deviate sufficiently
from the mean to affect neonatal outcome. The sex dif-
ferences in fetal size in the second trimester are usually
small, corresponding to a few days difference in the
EDD [8]. The significant effects on prematurity-related
outcomes in our study are thus likely to be attributed to
those few fetuses with large discrepancies between the
actual and US-estimated GA.
Table 4 Adjusteda odds ratios (OR) with 95 % confidence intervals (95 % CI) for prematurity-related adverse outcomes by male sex
at birth in gestational week 35–36, and cohort ratios (CR) for the change in male risk before and after the implementation of ultra-
sound for pregnancy dating in Sweden
Outcome Birth Cohort
1973–1978 Odds
Ratioa,b (95 % CI)
Birth Cohort
1995–2010 Odds
Ratioa,b (95 % CI)
Cohort Ratios: Ratio of Male ORs
1995–2010 to 1973–1978
(95 % CI)
Neonatal death 1.15 (0.91–1.45) 0.95 (0.71–1.26) 0.82 (0.57–1.19)
Apgar score <7 at 5 min 1.08 (0.91–1.28) 1.26 (1.10–1.45) 1.17 (0.94–1.45)
Pneumothorax 1.70 (1.10–2.62) 2.27 (1.66–3.11) 1.34 (0.78–2.28)
RDSc 1.74 (1.40–2.16) 1.89 (1.56–2.28) 1.08 (0.81–1.45)
Other respiratory conditions 1.31 (1.12–1.54) 1.60 (1.48–1.72) 1.22 (1.02–1.45)
Hyperbilirubinemia 1.12 (1.03–1.20) 1.18 (1.12–1.23) 1.05 (0.96–1.15)
a Adjusted for maternal age, parity, and level of hospital care
b The reference category was female infants
c Respiratory distress syndrome of the newborn
Table 3 Adjusteda odds ratios (OR) with 95 % confidence intervals (95 % CI) for prematurity-related adverse outcomes by male sex
at birth in gestational week 37–38, and cohort ratios (CR) for the change in male risk before and after the implementation of ultra-
sound for pregnancy dating in Sweden
Outcome Birth Cohort
1973–1978 Odds
Ratioab (95 % CI)
Birth Cohort
1995–2010 Odds
Ratioab (95 % CI)
Cohort Ratios: Ratio of Male ORs
1995–2010 to 1973–1978
(95 % CI)
Neonatal death 1.28 (1.04–1.58) 1.36 (1.07–1.73) 1.06 (0.77–1.45)
Apgar score <7 at 5 min 1.07 (0.94–1.21) 1.35 (1.23–1.48) 1.26 (1.08–1.47)
Pneumothorax 1.44 (1.00–2.06) 2.95 (2.34–3.72) 2.05 (1.33–3.16)
RDSc 1.44 (1.11–1.87) 2.86 (2.11–3.89) 1.99 (1.33–2.98)
Other respiratory conditions 1.59 (1.41–1.80) 1.81 (1.71–1.92) 1.14 (1.00–1.30)
Hyperbilirubinemia 1.17 (1.12–1.23) 1.31 (1.26–1.36) 1.12 (1.06–1.19)
a Adjusted for maternal age, parity, and level of hospital care
b The reference category was female infants
c Respiratory distress syndrome of the newborn
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In the clinical setting, when US biometry is used for
pregnancy dating, one should take into consideration bio-
logical [6] and methodological [31] variance. When there
is a large discrepancy between LMP date- and US-based
estimations [10], clinicians should try to combine available
data in order to get the best estimate of GA before clinical
decision-making. For example, for pregnancies after IVF,
the day of embryo transfer is often preferred to US biom-
etry for assessing GA. In other cases, pregnant women
can sometimes provide precise information on the days
around which conception took place, which can be of
added value. As the variance in growth increases with GA,
a first-trimester estimation of GA would be preferred to a
second-trimester scan for the purpose of pregnancy dating
[3, 4]. The misclassification bias due to sex differences in
fetal growth [9] can be reduced using first-trimester US
biometry [32], and an increasing use of first trimester
ultrasound in Sweden will probably improve precision of
GA estimates which would help to optimize neonatal care.
However, one should bear in mind that even such assess-
ments can be biased by early growth restriction [33]. A
large discrepancy between the estimates derived from US-
examination and the date of LMP might constitute an in-
dication for a repeat scan, as it suggests higher odds for
adverse outcomes such as early growth restriction [34].
Conclusions
There was a significant reduction of infant morbidity be-
tween the two study periods, as expected. However, male
infants on the edge of prematurity have not benefitted as
much as female infants in terms of prematurity-related
outcomes. This might reflect a bias introduced by the
pregnancy dating method, as a proportion of male infants
might be more premature at birth than estimated and thus
more prone to prematurity-related adverse outcomes.
Misclassification of GA because of sex differences in fetal
size could thus partially explain the currently reported
male disadvantage in neonatal outcomes of early term and
late preterm infants, and should be taken into account in
clinical decisions and when interpreting study results re-
lated to fetal sex.
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